| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.034 | 0.5 |